United Health Products, Inc. (UEEC)
OTCMKTS · Delayed Price · Currency is USD
0.0380
-0.0010 (-2.56%)
Aug 25, 2026, 11:19 AM EST
United Health Products Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.02 | 0.07 | 0.17 | 0.1 | 0.01 | 0.02 |
Cash & Short-Term Investments | 0.02 | 0.07 | 0.17 | 0.1 | 0.01 | 0.02 |
Cash Growth | 10786.67% | -61.36% | 76.99% | 613.31% | -38.64% | -52.69% |
Inventory | - | - | - | 0.03 | 0.03 | - |
Prepaid Expenses | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.01 |
Total Current Assets | 0.06 | 0.11 | 0.19 | 0.15 | 0.07 | 0.03 |
Property, Plant & Equipment | - | 0.01 | 0.05 | 0.08 | - | - |
Other Intangible Assets | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | - |
Long-Term Deferred Charges | 0.16 | 0.17 | - | 0.02 | 0.24 | - |
Other Long-Term Assets | - | 0 | 0 | 0 | - | - |
Total Assets | 0.25 | 0.32 | 0.27 | 0.28 | 0.35 | 0.03 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.11 | 0.88 | 0.77 | 0.87 | 1.26 | 0.83 |
Accrued Expenses | 1.1 | 1.12 | 0.84 | 0.34 | 0.17 | 0 |
Short-Term Debt | 0.08 | - | - | 0.71 | 0.69 | 0.22 |
Current Portion of Long-Term Debt | 1.75 | 1.78 | - | - | - | - |
Current Portion of Leases | - | 0.02 | 0.03 | 0.03 | - | - |
Other Current Liabilities | - | - | - | - | 0.3 | 0.12 |
Total Current Liabilities | 4.19 | 3.94 | 1.64 | 1.95 | 2.42 | 1.17 |
Long-Term Debt | 0.5 | 0.25 | 1.06 | - | - | - |
Long-Term Leases | - | - | 0.02 | 0.05 | - | - |
Total Liabilities | 4.69 | 4.19 | 2.71 | 2 | 2.42 | 1.17 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.26 | 0.26 | 0.25 | 0.24 | 0.23 | 0.23 |
Additional Paid-In Capital | 77.37 | 77.24 | 76 | 74.74 | 71.83 | 71.02 |
Retained Earnings | -82.08 | -81.37 | -78.7 | -76.7 | -74.08 | -72.39 |
Comprehensive Income & Other | - | - | - | - | -0.05 | - |
Shareholders' Equity | -4.44 | -3.88 | -2.44 | -1.71 | -2.06 | -1.14 |
Total Liabilities & Equity | 0.25 | 0.32 | 0.27 | 0.28 | 0.35 | 0.03 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.33 | 2.04 | 1.11 | 0.78 | 0.69 | 0.22 |
Net Cash (Debt) | -2.31 | -1.98 | -0.94 | -0.69 | -0.67 | -0.2 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
Filing Date Shares Outstanding | 262.69 | 258.69 | 252.41 | 246.83 | 234.34 | 228.83 |
Total Common Shares Outstanding | 262.69 | 258.69 | 252.41 | 244.78 | 230.87 | 228.67 |
Working Capital | -4.12 | -3.84 | -1.45 | -1.8 | -2.34 | -1.14 |
Book Value Per Share | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 |
Tangible Book Value | -4.47 | -3.9 | -2.47 | -1.75 | -2.1 | -1.14 |
Tangible Book Value Per Share | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.00 |